3 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Tarsier Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRS4Vision - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma TRS01, FDA approved steroid eye drop (masked) - Non-infectious Anterior Uveitis, Uveitic Glaucoma | Phase 3 | Completed | Tarsier Pharma | 142 | 2021-09-20 | 2026-10-22 |
| A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis TRS01 eye drops - Non-infectious Anterior Uveitis | Phase 1 / Phase 2 | Completed | Tarsier Pharma | 16 | 2020-02-01 | 2023-10-05 |
| A Study of TRS01 in Participants With Post-surgical Ocular Inflammation TRS01 eye drops, Placebo eye drops - Post Surgical Ocular Inflammation | Phase 1 / Phase 2 | Completed | Tarsier Pharma | 37 | 2020-02-01 | 2021-10-14 |
Inflammation (1) · Pain (1)
Masks (1)
United States (3) · France (1) · Germany (1)
2019 (1)